07.08.2019 - By The Heartland Institute
A U.S. Senate subcommittee panel is considering a proposal to reverse two U.S. Supreme Court rulings that limit patent eligibility for gene sequencing. Dr. Roger Klein explains why this could upend the medical diagnostics industry.